Israeli scientists at Jerusalem’s Shaare Zedek Medical Center and Bar-Ilan University have developed eyedrops that repair the corneas, improving near-sighted and far-sighted vision. The “nanodrops” are scheduled for human trials next year and could eventually replace multifocal lenses.
International scientists, including from Israel’s Hebrew University of Jerusalem and University of Haifa, have discovered a genetic mutation associated with Crohn’s disease. Those with the LRRK2 gene mutation are at high risk of developing the inflammatory bowel (IBD) disease.
I’ve reported previously (several times) on Israel’s IceCure and its IceSense3 cryoablation (freezing) system for destroying even large tumors. This article and video provide an excellent explanation of how the system works, in conjunction with other medications and the immune system.
Israel’s Engineering for All (EfA) is developing RevDx - a small, portable device that can perform automated blood tests, diagnostics, and data analytics on the spot; a kind of hand-held hospital to assist under-equipped medical workers and technicians in rural areas.
93-year-old former president of Kenya, Daniel Arap Moi is being brought to Tel Aviv for medical procedures. The ailing leader will also take the opportunity to visit holy sites around the country, Kenyan TV reported.
Israeli startup Nucleai is developing computer vision and artificial intelligence (AI) to help overworked pathologists process and analyze biopsies for cancer quicker and more accurately. Nucleai founders have years of experience of computer vision gained during their IDF service.
The tech-transfer company of Ben-Gurion University, plus Israeli-founded, Singapore-based Biosensorix, are developing $5 disease diagnosis kits that connect to a smartphone via its USB port. Instead of sending samples for lab tests, medical staff can get immediate blood test results and decide on a course of action.
Russian Jewish billionaire Roman Abramovich has donated $20 million to Israel’s Sheba Medical Center to build a new medical center for nuclear medicine and research. Its cyclotron particle accelerator will use radioactive ion beams to pinpoint and kill cancer cells.
The UK has launched a new £5m fund to promote scientific collaboration and research between Israel and the UK into the aging process. The Britain Israel Research and Academic Exchange (BIRAX) Aging fund will also promote research that into aging-related diseases.
Scientists at Israel’s Weizmann Institute have found from a study of over 1,000 Israelis that there is no genetic link to the good bacteria in your gut (microbiome). A person’s health (cholesterol, weight, blood glucose levels etc.) however, can be controlled by maintaining a healthy stomach.